Acceleration of protein aggregation by amphiphilic peptides: Transformation of supramolecular structure of the aggregates

Biotechnology Progress

Volumn 27, Issue 3, 2011, Pages 846-854

  Artemova, N V ^a   Stein Margolina, V A ^a   Bumagina, Z M ^a   Gurvits, B Ya ^a  

^a BACH INSTITUTE OF BIOCHEMISTRY   (Russian Federation)

Author keywords

Amphiphilic peptides; Dynamic light scattering; Electron microscope; Protein aggregation; Supramolecular structures

Indexed keywords

AGGREGATION PROCESS; AMPHIPHILIC PEPTIDES; AMPHIPHILICS; AMYLOID-LIKE FIBRIL; BUILDING BLOCKES; COMPLEMENTARY PROTEINS; CONTROL SAMPLES; DIFFERENT STRUCTURE; DIPEPTIDE; FIBRILLAR STRUCTURES; INDIVIDUAL PROTEINS; LIVING SYSTEMS; LOW MOLECULAR WEIGHT; MODEL PROTEINS; NATURAL PROTEINS; NET CHARGES; PHYSICOCHEMICAL PROPERTY; PROTEIN AGGREGATES; PROTEIN AGGREGATION; PROTEIN SUBSTRATE; SPHERICAL PARTICLE; STRUCTURE FORMATIONS; SUPRAMOLECULAR STRUCTURE;

AGGLOMERATION; BIOLOGICAL MATERIALS; BIOMATERIALS; DYNAMIC LIGHT SCATTERING; FLUORESCENCE SPECTROSCOPY; MOLECULAR BIOLOGY; MOLECULAR RECOGNITION; NANOSTRUCTURES; REFRACTION; SELF ASSEMBLY; SUBSTRATES; TRANSMISSION ELECTRON MICROSCOPY;

PEPTIDES;

DIPEPTIDE; LACTALBUMIN; PEPTIDE; SURFACTANT;

ARTICLE; CHEMISTRY; MACROMOLECULE; PROTEIN MULTIMERIZATION;

DIPEPTIDES; LACTALBUMIN; MACROMOLECULAR SUBSTANCES; PEPTIDES; PROTEIN MULTIMERIZATION; SURFACE-ACTIVE AGENTS;

EID: 79958248557     PISSN: 87567938     EISSN: 15206033     Source Type: Journal    
DOI: 10.1002/btpr.574     Document Type: Article

References (45)

1. Chiti F, Dobson CM. Protein misfolding, functional amyloid, and human disease. Annu Rev Biochem. 2006; 75: 333-366.
2. Bucciantini M, Giannoni E, Chiti F, Baroni F, Formigli L, Zurdo J, Taddei N, Ramponi G, Dobson CM, Stefani M. Inherent toxicity of aggregates implies a common mechanism for protein misfolding diseases. Nature. 2002; 416: 507-511.
3. Gazit E. Mechanisms of amyloid fibril self-assembly and inhibition. Model short peptides as a key research tool. FEBS J. 2005; 272: 5971-5978.
4. Reches M, Porat Y, Gazit E. Amyloid fibril formation by pentapeptide and tetrapeptide fragments of human calcitonin. J Biol Chem. 2002; 277: 35475-35480.
5. Ben-Zvi AP, Goloubinoff P. Proteinaceous infectious behavior in non-pathogenic proteins is controlled by molecular chaperones. J Biol Chem. 2002; 277: 49422-49427.
6. Dobson CM. Principles of protein folding, misfolding and aggregation. Semin Cell Dev Biol. 2004; 15: 3-16.
7. Krebs MRH, Devlin GL, Donald AM. Protein particulates: another generic form of protein aggregation? Biophys J. 2007; 92: 1336-1342.
8. Gebbink MF, Claessen D, Bouma B, Dijkhuizen L, Wösten HA. Amyloids-a functional coat for microorganisms. Nat Rev Microbiol. 2005; 3: 333-341.
9. Kelly JW, Balch EW. Amyloid as a natural product. J Cell Biol. 2003; 161: 461-462.
10. Stefani M. Protein misfolding and aggregation: new examples in medicine and biology of the dark side of the protein world. Biochim Biophys Acta. 2004; 1739: 5-25.
11. Artemova NV, Kasakov AS, Bumagina ZM, Lyutova EM, Gurvits BYa. Protein aggregates as depots for the release of biologically active compounds. Biochem Biophys Res Commun. 2008; 377: 595-599.
12. Stefani M, Dobson CM. Protein aggregation and aggregate toxicity: new insights into protein folding, misfolding diseases and biological evolution. J Mol Med. 2003; 81: 678-699.
13. Natalello A, Santarella R, Doglia SM, de Marco A. Physical and chemical perturbations induce the formation of protein aggregates with different structural features. Protein Expr Purif. 2008; 58: 356-361.
14. Vera A, González-Montalbán N, Arís A, Villaverde A. The conformational quality of insoluble recombinant proteins is enhanced at low growth temperatures. Biotechnol Bioeng. 2007; 96: 1101-1106.
15. Nigen M, Gaillard C, Croguennec T, Madec M-N, Bouhallab S. Dynamic and supramolecular organisation of α-lactalbumin/lysozyme microspheres: a microscopic study. Biophys Chem. 2010; 146: 30-35.
16. Trivedi VD, Raman B, Rao CM, Ramakrishna T. Co-refolding denatured-reduced hen egg white lysozyme with acidic and basic proteins. FEBS Lett. 1997; 418: 363-366.
17. Kudou M, Shiraki K, Fujiwara S, Imanaka T, Takagi M. Prevention of thermal inactivation and aggregation of lysozyme by polyamines. Eur J Biochem. 2003; 270: 4547-4554.
18. Shalova IN, Asryants RA, Sholukh MV, Saso L, Kurganov BI, Muronetz VI, Izumrudov VA. Interaction of polyanions with basic proteins: influence of complexing polyanions on the thermoaggregation of oligomeric enzymes. Macromol Biosci. 2005; 5: 1184-1192.
19. Antony T, Hoyer W, Cherny D, Heim G, Jovin TM, Subramaniam V. Cellular polyamines promote the aggregation of α-synuclein. J Biol Chem. 2003; 278: 3235-3240.
20. Bouma B, Kroon-Batenburg LMJ, Wu Y-P, Brunjes B, Posthuma G, Kranenburg O, Groot PG, Voest EE, Gebbink MFBG. Glycation induces formation of amyloid cross-β structure in albumin. J Biol Chem. 2003; 278: 41810-41819.
21. Chakraborty A, Basak S. Interaction with Al and Zn induces structure formation and aggregation in natively unfolded caseins. J Photochem Photobiol. 2008; 93: 36-43.
22. Uversky VN, Li J, Fink AL. Metal-triggered structural transformations, aggregation, and fibrillation of human α-synuclein. J Biol Chem. 2001; 276: 44284-44296.
23. Chiti F, Taddei N, Stefani M, Dobson CM, Ramponi G. Reduction of the amyloidogenicity of a protein by specific binding of ligands to the native conformation. Protein Sci. 2001; 10: 879-886.
24. Tsumoto K, Umetsu M, Kumagai I, Ejima D, Philo JS, Arakawa T. Role of arginine in protein refolding, solubilization, and purification. Biotechnol Prog. 2004; 20: 1301-1308.
25. Yang F, Lim GP, Begum AN, Ubeda OJ, Simmons MR, Ambegaokar SS, Chen P, Kayed R, Glabe CG, Frautschy SA, Cole GM. Curcumin inhibits formation of amyloid β oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J Biol Chem. 2005; 280: 5892-5901.
26. Evers F, Jeworrek C, Tiemeyer S, Weise K, Sellin D, Paulus M, Struth B, Tolan M, Winter R. Elucidating the mechanism of lipid membrane-induced IAPP fibrillogenesis and its inhibition by the red wine compound resveratrol: a synchrotron X-ray reflectivity study. J Am Chem Soc. 2009; 131: 9516-9521.
27. Thorn DC, Meehan S, Sunde M, Rekas A, Gras SL, MacPhee CE, Dobson CM, Wilson MR, Carver JA. Amyloid fibril formation by bovine milk kappa-casein and its inhibition by the molecular chaperones alphaS- and beta-casein. Biochemistry. 2005; 44: 17027-17036.
28. Velkova A, Tatarek-Nossol M, Andreetto E, Kapurniotu A. Exploiting cross-amyloid interactions to inhibit protein aggregation but not function: nanomolar affinity inhibition of insulin aggregation by an IAPP mimic. Angew Chem Int Ed. 2008; 47: 7114-7118.
29. Natalello A, Liu J, Ami D, Doglia SM, de Marco A. The osmolyte betaine promotes protein misfolding and disruption of protein aggregates. Proteins. 2009; 75: 509-517.
30. Kuwajima K. The molten globule state of α-lactalbumin. FASEB J. 1996; 10: 102-109.
31. Christina ED, Brew K, Acharya KR. Crystal structure of apo- and holo-bovine α-lactalbumin at 2.2-A resolution reveal an effect of calcium on inter-lobe interaction. J Biol Chem. 2000; 275: 37021-37029.
32. Bettelheim FA, Ansari R, Cheng Q-F, Zigler JS Jr. The mode of chaperoning of dithiothreitol-denatured α-lactalbumin by α-crystallin. Biochem Biophys Res Commun. 1999; 261: 292-297.
33. Takase K, Higashi T, Omura T. Aggregate formation and the structure of the aggregates of disulfide-reduced proteins. J Protein Chem. 2002; 21: 427-433.
34. Iyer LK, Qasba PK. Molecular dynamics simulation of α-lactalbumin and calcium binding c-type lysozyme. Protein Eng. 1999; 12: 129-139.
35. McKenzie HA, White FHJ. Lysozyme and α-lactalbumin: structure, function, and interrelationships. Adv Protein Chem. 1991; 41: 173-315.
36. LeVine H. Quantification of β-sheet amyloid fibril structures with thioflavin T. Methods Enzymol. 1999; 309: 274-284.
37. Naiki H, Higuchi K, Hosokawa M, Takeda T. Fluorimetric determination of amyloid fibrils in vitro using the fluorescent dye, thioflavin T1. Anal Biochem. 1989; 177: 244-249.
38. Bumagina ZM, Gurvits BYa, Artemova NV, Muranov KO, Yudin IK, Kurganov BI. Mechanism of suppression of dithiothreitol-induced aggregation of bovine α-lactalbumin by α-crystallin. Biophys Chem. 2010; 146: 108-117.
39. Horwitz J. Alpha-crystallin can function as a molecular chaperone. Proc Natl Acad Sci USA. 1992; 89: 10449-10453.
40. Cserhaty T, Szogy M. Role of hydrophobic and hydrophilic forces in peptide-protein interaction: new advances. Peptides. 1995; 16: 165-173.
41. Bhatia R, Lin H, Lal R. Fresh and globular amyloid beta protein (1-42) induces rapid cellular degeneration: evidence for AbetaP channel-mediated cellular toxicity. FASEB J. 2000; 14: 1233-1243.
42. Ellis-Behnke RG, Liang Y-X, You S-W, Tay DKC, Zhang S, So K-F, Schneider GE. Nano neuro knitting: peptide nanofiber scaffold for brain repair and axon regeneration with functional return of vision. Proc Natl Acad Sci USA. 2006; 103: 5054-5059.
43. Bemporad F, Taddei N, Stefani M, Chiti F. Assessing the role of aromatic residues in the amyloid aggregation of human muscle acylphosphatase. Protein Sci. 2006; 15: 862-870.
44. Makin OS, Atkins E, Sikorski P, Johansson J, Serpell LC. Molecular basis for amyloid fibril formation and stability. Proc Natl Acad Sci USA. 2005; 102: 315-320.
45. Naito A, Kamihira M, Inoue R, Saito H. Structural diversity of amyloid fibril formed in human calcitonin as revealed by site-directed 13C solid-state NMR spectroscopy. Magn Reson Chem. 2004; 42: 247-257.